Oxolife is a small-size clinical-stage company focused on female fertility.
Oxolife has raised €4.9M across 2 funding rounds from 2 investors, most recently a Grant round in Feb 2026. Based in Barcelona, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-02-24 | Grant | €2.5M | EIC Accelerator | View deal → |
| 2022-12-13 | Grant | €2.4M | Spanish Science and Innovation Ministry | View deal → |
